[{"Year":2007,"Value":94.1,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2008,"Value":95.3,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2009,"Value":95.4,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2010,"Value":96.5,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2011,"Value":95.1,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2012,"Value":96.2,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2013,"Value":96.9,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2014,"Value":95.8,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2015,"Value":96.6,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2016,"Value":96.1,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2017,"Value":93.4,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2018,"Value":94.5,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2019,"Value":94.351083,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2020,"Value":88.157251,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2021,"Value":88.796593,"GeoCode":null,"SERIES":"Proportion of the target population with access to 3 doses of diphtheria-tetanus-pertussis (DTP3)"},{"Year":2007,"Value":98.8,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2008,"Value":99.1,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2009,"Value":98.9,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2010,"Value":98.3,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2011,"Value":97.2,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2012,"Value":97.7,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2013,"Value":98.666102,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2014,"Value":95.6,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2015,"Value":99.1,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2016,"Value":97.0,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2017,"Value":94.7,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2018,"Value":96.244215,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2019,"Value":97.245414,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2020,"Value":93.789319,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2021,"Value":93.378399,"GeoCode":null,"SERIES":"Proportion of the target population with access to measles-containing-vaccine second-dose (MCV2)"},{"Year":2015,"Value":96.8,"GeoCode":null,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":2016,"Value":97.2,"GeoCode":null,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":2017,"Value":94.2,"GeoCode":null,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":2018,"Value":92.0,"GeoCode":null,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":2019,"Value":95.083643,"GeoCode":null,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":2020,"Value":88.782542,"GeoCode":null,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"},{"Year":2021,"Value":89.631204,"GeoCode":null,"SERIES":"Proportion of the target population with access to pneumococcal conjugate 3rd dose (PCV3)"}]